Screener
Relay Therapeutics, Inc. RLAY Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s current ratio?
- Relay Therapeutics, Inc. (RLAY) reported current ratio of 18.3× in Q2 2026.
- How has Relay Therapeutics, Inc.'s current ratio changed year-over-year?
- Relay Therapeutics, Inc.'s current ratio decreased by 12.7% year-over-year, from 20.9× to 18.3×.
- What is the long-term trend for Relay Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s current ratio has grown at a -16.7% compound annual growth rate (CAGR), from 56.5× to 22.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Relay Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude